Age-related changes in memory and effector T cells responding to influenza A/H3N2 and pandemic A/H1N1 strains in humans

Vaccine

Volumn 29, Issue 11, 2011, Pages 2169-2177

  Zhou, Xin ^a   McElhaney, Janet E ^a,b  

^a UNIVERSITY OF CONNECTICUT SCHOOL OF MEDICINE   (United States)

^b UNIVERSITY OF BRITISH COLUMBIA   (Canada)

Author keywords

Cytolytic T cell response; Human T cell subsets; Influenza A H3N2 and pandemic H1N1 strains; Influenza vaccination

Indexed keywords

INFLUENZA VACCINE;

ADULT; AGED; ARTICLE; CD8+ T LYMPHOCYTE; CONCENTRATION RESPONSE; CONTROLLED STUDY; CYTOLYSIS; EFFECTOR CELL; FEMALE; GROUPS BY AGE; HUMAN; HUMAN CELL; INFECTION PREVENTION; INFLUENZA A (H1N1); INFLUENZA A (H3N2); INFLUENZA VACCINATION; INFLUENZA VIRUS A H1N1; INFLUENZA VIRUS A H3N2; MAJOR CLINICAL STUDY; MALE; MEMORY T LYMPHOCYTE; PANDEMIC; PHENOTYPE; PRIORITY JOURNAL; T LYMPHOCYTE SUBPOPULATION; VIRUS STRAIN;

ADULT; AGED; AGED, 80 AND OVER; AGING; CD4-POSITIVE T-LYMPHOCYTES; CD8-POSITIVE T-LYMPHOCYTES; CELL PROLIFERATION; CELLS, CULTURED; GRANZYMES; HUMANS; IMMUNITY, CELLULAR; IMMUNOLOGIC MEMORY; INFLUENZA A VIRUS, H1N1 SUBTYPE; INFLUENZA A VIRUS, H3N2 SUBTYPE; INFLUENZA VACCINES; INFLUENZA, HUMAN; MIDDLE AGED; PERFORIN; PHENOTYPE; T-LYMPHOCYTE SUBSETS; YOUNG ADULT;

EID: 79951786443     PISSN: 0264410X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.vaccine.2010.12.029     Document Type: Article

References (41)

1. Pawelec G., Akbar A., Caruso C., Solana R., Grubeck-Loebenstein B., Wikby A. Human immunosenescence: is it infectious?. Immunol Rev 2005, 205(June):257-268.
2. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Cox N., Anderson L.J., et al. Mortality associated with influenza and respiratory syncytial virus in the United States. JAMA 2003, 289(January (2)):179-186.
3. Thompson W.W., Shay D.K., Weintraub E., Brammer L., Bridges C.B., Cox N.J., et al. Influenza-associated hospitalizations in the United States. JAMA 2004, 292(September (11)):1333-1340.
4. Update: influenza activity-United States, August 30, 2009-January 9, 2010. Morb Mortal Wkly Rep;59:38-43.
5. Outbreaks of 2009 pandemic influenza A (H1N1) among long-term-care facility residents-three states, Morb Mortall Wkly Rep 2009;59:74-7.
6. Nichol K.L., Margolis K.L., Wuorenma J., Von Sternberg T. The efficacy and cost effectiveness of vaccination against influenza among elderly persons living in the community. N Engl J Med 1994, 331(September (12)):778-784.
7. McElhaney J.E., Xie D., Hager W.D., Barry M.B., Wang Y., Kleppinger A., et al. T cell responses are better correlates of vaccine protection in the elderly. J Immunol 2006, 176(May (10)):6333-6339.
8. McElhaney J.E., Ewen C., Zhou X., Kane K.P., Xie D., Hager W.D., et al. Granzyme B: correlates with protection and enhanced CTL response to influenza vaccination in older adults. Vaccine 2009, 27(April (18)):2418-2425.
9. McMichael A.J., Gotch F.M., Noble G.R., Beare P.A. Cytotoxic T-cell immunity to influenza. N Engl J Med 1983, 309(July (1)):13-17.
10. Johnson B.J., Costelloe E.O., Fitzpatrick D.R., Haanen J.B., Schumacher T.N., Brown L.E., et al. Single-cell perforin and granzyme expression reveals the anatomical localization of effector CD8+ T cells in influenza virus-infected mice. Proc Natl Acad Sci USA 2003, 100(March (5)):2657-2662.
11. Lord S.J., Rajotte R.V., Korbutt G.S., Bleackley R.C. Granzyme B: a natural born killer. Immunol Rev 2003, 193(June):31-38.
12. Lawrence C.W., Ream R.M., Braciale T.J. Frequency, specificity, and sites of expansion of CD8+ T cells during primary pulmonary influenza virus infection. J Immunol 2005, 174(May (9)):5332-5340.
13. Pfister G., Weiskopf D., Lazuardi L., Kovaiou R.D., Cioca D.P., Keller M., et al. Naive T cells in the elderly: are they still there?. Ann N Y Acad Sci 2006, 1067(May):152-157.
14. McElhaney J.E., Pinkoski M.J., Upshaw C.M., Bleackley R.C. The cell-mediated cytotoxic response to influenza vaccination using an assay for granzyme B activity. J Immunol Methods 1996, 190(March (1)):11-20.
15. Powers D.C., McElhaney J.E., Florendo O.A., Manning M.C., Upshaw C.M., Bentley D.W., et al. Humoral and cellular immune responses following vaccination with purified recombinant hemagglutinin from influenza A (H3N2) virus. J Infect Dis 1997, 175(February (2)):342-351.
16. Sallusto F., Lenig D., Forster R., Lipp M., Lanzavecchia A. Two subsets of memory T lymphocytes with distinct homing potentials and effector functions. Nature 1999, 401(October (6754)):708-712.
17. Olsson J., Wikby A., Johansson B., Lofgren S., Nilsson B.O., Ferguson F.G. Age-related change in peripheral blood T-lymphocyte subpopulations and cytomegalovirus infection in the very old: the Swedish longitudinal OCTO immune study. Mech Ageing Dev 2000, 121(December (1-3)):187-201.
18. Russell J.H., Ley T.J. Lymphocyte-mediated cytotoxicity. Annu Rev Immunol 2002, 20:323-370.
19. Barry M., Bleackley R.C. Cytotoxic T lymphocytes: all roads lead to death. Nat Rev Immunol 2002, 2(June (6)):401-409.
20. Touvrey C., Derre L., Devevre E., Corthesy P., Romero P., Rufer N., et al. Dominant human CD8 T cell clonotypes persist simultaneously as memory and effector cells in memory phase. J Immunol 2009, 182(June (11)):6718-6726.
21. Shahid Z., Kleppinger A., Gentleman B., Falsey A.R., McElhaney J.E. Clinical and immunologic predictors of influenza illness among vaccinated older adults. Vaccine 2010, 28(August (38)):6145-6151.
22. Betts M.R., Brenchley J.M., Price D.A., De Rosa S.C., Douek D.C., Roederer M., et al. Sensitive and viable identification of antigen-specific CD8+T cells by a flow cytometric assay for degranulation. J Immunol Methods 2003, 281(October (1-2)):65-78.
23. van Leeuwen E.M., de Bree G.J., Remmerswaal E.B., Yong S.L., Tesselaar K., ten Berge I.J., et al. IL-7 receptor alpha chain expression distinguishes functional subsets of virus-specific human CD8+ T cells. Blood 2005, 106(September (6)):2091-2098.
24. de Bree G.J., van Leeuwen E.M., Out T.A., Jansen H.M., Jonkers R.E., van Lier R.A. Selective accumulation of differentiated CD8+ T cells specific for respiratory viruses in the human lung. J Exp Med 2005, 202(November (10)):1433-1442.
25. Effros R.B. Role of T lymphocyte replicative senescence in vaccine efficacy. Vaccine 2007, 25(January (4)):599-604.
26. ; 2009. http://www.cdc.gov/h1n1flu/vaccination/accine_seniros.htm.
27. Goronzy J.J., Fulbright J.W., Crowson C.S., Poland G.A., O'Fallon W.M., Weyand C.M. Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol 2001, 75(December (24)):12182-12187.
28. Saurwein-Teissl M., Lung T.L., Marx F., Gschosser C., Asch E., Blasko I., et al. Lack of antibody production following immunization in old age: association with CD8(+)CD28(-) T cell clonal expansions and an imbalance in the production of Th1 and Th2 cytokines. J Immunol 2002, 168(June (11)):5893-5899.
29. Effros R.B., Dagarag M., Spaulding C., Man J. The role of CD8+ T-cell replicative senescence in human aging. Immunol Rev 2005, 205(June):147-157.
30. Casazza J.P., Betts M.R., Price D.A., Precopio M.L., Ruff L.E., Brenchley J.M., et al. Acquisition of direct antiviral effector functions by CMV-specific CD4+ T lymphocytes with cellular maturation. J Exp Med 2006, 203(December (13)):2865-2877.
31. Sylwester A.W., Mitchell B.L., Edgar J.B., Taormina C., Pelte C., Ruchti F., et al. Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects. J Exp Med 2005, 202(September (5)):673-685.
32. de Bree G.J., Daniels H., Schilfgaarde M., Jansen H.M., Out T.A., van Lier R.A., et al. Characterization of CD4+ memory T cell responses directed against common respiratory pathogens in peripheral blood and lung. J Infect Dis 2007, 195(June (11)):1718-1725.
33. de Bree G.J., Heidema J., van Leeuwen E.M., van Bleek G.M., Jonkers R.E., Jansen H.M., et al. Respiratory syncytial virus-specific CD8+ memory T cell responses in elderly persons. J Infect Dis 2005, 191(May (10)):1710-1718.
34. Kang I., Hong M.S., Nolasco H., Park S.H., Dan J.M., Choi J.Y., et al. Age-associated change in the frequency of memory CD4+ T cells impairs long term CD4+ T cell responses to influenza vaccine. J Immunol 2004, 173(July (1)):673-681.
35. Gardner E.M., Gonzalez E.W., Nogusa S., Murasko D.M. Age-related changes in the immune response to influenza vaccination in a racially diverse, healthy elderly population. Vaccine 2006, 24(March (10)):1609-1614.
36. Pebody R.G., McLean E., Zhao H., Cleary P., Bracebridge S., Foster K., et al. Pandemic Influenza A (H1N1) 2009 and mortality in the United Kingdom: risk factors for death, April 2009 to March 2010. Euro Surveill 2010, 15(May (20)).
37. Hadler J.L., Konty K., McVeigh K.H., Fine A., Eisenhower D., Kerker B., et al. Case fatality rates based on population estimates of influenza-like illness due to novel H1N1 influenza: New York City, May-June 2009. PLoS One 2010, 5(7):e11677.
38. Skowronski D.M., Hottes T.S., Janjua N.Z., Purych D., Sabaiduc S., Chan T., et al. Prevalence of seroprotection against the pandemic (H1N1) virus after the 2009 pandemic. CMAJ 2010, 182(November (17)):1851-1856.
39. Hammarlund E., Lewis M.W., Hansen S.G., Strelow L.I., Nelson J.A., Sexton G.J., et al. Duration of antiviral immunity after smallpox vaccination. Nat Med 2003, 9(September (9)):1131-1137.
40. Amara R.R., Nigam P., Sharma S., Liu J., Bostik V. Long-lived poxvirus immunity, robust CD4 help, and better persistence of CD4 than CD8 T cells. J Virol 2004, 78(April (8)):3811-3816.
41. Combadiere B., Boissonnas A., Carcelain G., Lefranc E., Samri A., Bricaire F., et al. Distinct time effects of vaccination on long-term proliferative and IFN-gamma-producing T cell memory to smallpox in humans. J Exp Med 2004, 199(June (11)):1585-1593.